﻿{"id":29757,"date":"2025-11-11T09:36:29","date_gmt":"2025-11-11T02:36:29","guid":{"rendered":"https:\/\/nhathuocngocanh.com\/bp\/?p=29757"},"modified":"2025-11-11T09:36:29","modified_gmt":"2025-11-11T02:36:29","slug":"tetryzoline-hydrochloride","status":"publish","type":"post","link":"https:\/\/nhathuocngocanh.com\/bp\/tetryzoline-hydrochloride\/","title":{"rendered":"Tetryzoline Hydrochloride"},"content":{"rendered":"<p>BP 2025 (Ph. Eur. 11.6 update)<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone  wp-image-29773\" src=\"https:\/\/nhathuocngocanh.com\/bp\/wp-content\/uploads\/2025\/11\/Tetryzoline-Hydrochloride-1.jpg\" alt=\"Tetryzoline Hydrochloride\" width=\"635\" height=\"344\" srcset=\"https:\/\/nhathuocngocanh.com\/bp\/wp-content\/uploads\/2025\/11\/Tetryzoline-Hydrochloride-1.jpg 1200w, https:\/\/nhathuocngocanh.com\/bp\/wp-content\/uploads\/2025\/11\/Tetryzoline-Hydrochloride-1-300x163.jpg 300w, https:\/\/nhathuocngocanh.com\/bp\/wp-content\/uploads\/2025\/11\/Tetryzoline-Hydrochloride-1-1024x555.jpg 1024w, https:\/\/nhathuocngocanh.com\/bp\/wp-content\/uploads\/2025\/11\/Tetryzoline-Hydrochloride-1-768x416.jpg 768w\" sizes=\"auto, (max-width: 635px) 100vw, 635px\" \/><\/p>\n<p>C<sub>13<\/sub>H<sub>17<\/sub>ClN<sub>2<\/sub> 236.7 522-48-5<\/p>\n<p><strong>Action and use<\/strong><\/p>\n<p>Adrenoceptor agonist; decongestant.<\/p>\n<h2>DEFINITION<\/h2>\n<p>2-[(1RS)-1,2,3,4-Tetrahydronaphthalen-1-yl]-4,5-dihydro-1H-imidazole hydrochloride.<\/p>\n<p><strong>Content<\/strong><\/p>\n<p>98.0 per cent to 101.0 per cent (dried substance).<\/p>\n<h2>CHARACTERS<\/h2>\n<p><strong>Appearance<\/strong><\/p>\n<p>White or almost white, crystalline powder.<\/p>\n<p><strong>Solubility<\/strong><\/p>\n<p>Freely soluble in water, in anhydrous ethanol and in ethanol (96 per cent), practically insoluble in acetone.<\/p>\n<h2>IDENTIFICATION<\/h2>\n<p>A. Infrared absorption spectrophotometry (2.2.24).<\/p>\n<p>Comparison tetryzoline hydrochloride CRS.<\/p>\n<p>B. Dissolve 50 mg in 10 mL of water R. The solution gives reaction (a) of chlorides (2.3.1).<\/p>\n<h2>TESTS<\/h2>\n<p><strong>Appearance of solution<\/strong><\/p>\n<p>The solution is clear (2.2.1) and colourless (2.2.2, Method II).<\/p>\n<p>Dissolve 1.0 g in water R and dilute to 10 mL with the same solvent.<\/p>\n<p><strong>Related substances<\/strong><\/p>\n<p>Gas chromatography (2.2.28).<\/p>\n<p>Test solution Dissolve 1.0 g of the substance to be examined in a mixture of 25 volumes of 1 M sodium hydroxide and<\/p>\n<p>75 volumes of methanol R and dilute to 10 mL with the same mixture of solvents.<\/p>\n<p>Reference solution Dilute 1.0 mL of the test solution to 100.0 mL with a mixture of 25 volumes of 1 M sodium hydroxide and 75 volumes of methanol R. Dilute 1.0 mL of this solution to 10.0 mL with a mixture of 25 volumes of 1 M sodium hydroxide and 75 volumes of methanol R.<\/p>\n<p>Column:<\/p>\n<p>\u2014 material: fused silica,<br \/>\n\u2014 size: l = 25 m, \u00d8 = 0.32 mm,<br \/>\n\u2014 stationary phase: methylpolysiloxane R (1 \u03bcm).<\/p>\n<p>Carrier gas helium for chromatography R.<\/p>\n<p>Split ratio 1:40.<\/p>\n<p>Flow rate 2.5 mL\/min.<\/p>\n<p>Temperature:<\/p>\n<table style=\"border-collapse: collapse; width: 100%; height: 126px;\">\n<tbody>\n<tr style=\"height: 21px;\">\n<td style=\"width: 33.3333%; height: 21px;\"><\/td>\n<td style=\"width: 33.3333%; height: 21px;\">Time<br \/>\n(min)<\/td>\n<td style=\"width: 33.3333%; height: 21px;\">Temperature<br \/>\n(\u00b0C)<\/td>\n<\/tr>\n<tr style=\"height: 21px;\">\n<td style=\"width: 33.3333%; height: 21px;\">Column<\/td>\n<td style=\"width: 33.3333%; height: 21px;\">0 &#8211; 8<\/td>\n<td style=\"width: 33.3333%; height: 21px;\">160<\/td>\n<\/tr>\n<tr style=\"height: 21px;\">\n<td style=\"width: 33.3333%; height: 21px;\"><\/td>\n<td style=\"width: 33.3333%; height: 21px;\">8 &#8211; 11<\/td>\n<td style=\"width: 33.3333%; height: 21px;\">160 \u2192 220<\/td>\n<\/tr>\n<tr style=\"height: 21px;\">\n<td style=\"width: 33.3333%; height: 21px;\"><\/td>\n<td style=\"width: 33.3333%; height: 21px;\">11 &#8211; 15<\/td>\n<td style=\"width: 33.3333%; height: 21px;\">220<\/td>\n<\/tr>\n<tr style=\"height: 21px;\">\n<td style=\"width: 33.3333%; height: 21px;\">Injection port<\/td>\n<td style=\"width: 33.3333%; height: 21px;\"><\/td>\n<td style=\"width: 33.3333%; height: 21px;\">220<\/td>\n<\/tr>\n<tr style=\"height: 21px;\">\n<td style=\"width: 33.3333%; height: 21px;\">Detector<\/td>\n<td style=\"width: 33.3333%; height: 21px;\"><\/td>\n<td style=\"width: 33.3333%; height: 21px;\">220<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Detection Flame ionisation.<\/p>\n<p>Injection 1 \u03bcL.<\/p>\n<p>Relative retention With reference to tetryzoline (retention time = about 12 min): impurity A = about 0.5.<\/p>\n<p>System suitability Reference solution:<br \/>\n\u2014 signal-to-noise ratio: minimum 50 for the principal peak.<\/p>\n<p>Limits:<br \/>\n\u2014 impurity A: not more than the area of the principal peak in the chromatogram obtained with the reference solution (0.1 per cent),<br \/>\n\u2014 any other impurity: for each impurity, not more than the area of the principal peak in the chromatogram obtained with the reference solution (0.1 per cent),<br \/>\n\u2014 total: not more than twice the area of the principal peak in the chromatogram obtained with the reference solution (0.2 per cent),<\/p>\n<p>\u2014 disregard limit: 0.5 times the area of the principal peak in the chromatogram obtained with the reference solution (0.05 per cent).<\/p>\n<p><strong>Loss on drying (2.2.32)<\/strong><\/p>\n<p>Maximum 0.5 per cent, determined on 1.000 g by drying in an oven at 105 \u00b0C.<\/p>\n<p><strong>Sulfated ash (2.4.14)<\/strong><\/p>\n<p>Maximum 0.1 per cent, determined on 1.0 g.<\/p>\n<h2>ASSAY<\/h2>\n<p>Dissolve 0.200 g in 100 mL of a mixture of 3 volumes of anhydrous acetic acid R and 7 volumes of acetic anhydride R.<\/p>\n<p>Titrate with 0.1 M perchloric acid, determining the end-point potentiometrically (2.2.20). Carry out a blank titration.<\/p>\n<p>1 mL of 0.1 M perchloric acid is equivalent to 23.67 mg of C<sub>13<\/sub>H<sub>17<\/sub>ClN<sub>2<\/sub><\/p>\n<h2>IMPURITIES<\/h2>\n<p>Specified impurities A.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone  wp-image-29771\" src=\"https:\/\/nhathuocngocanh.com\/bp\/wp-content\/uploads\/2025\/11\/Tetryzoline-Hydrochloride-3.jpg\" alt=\"Tetryzoline Hydrochloride\" width=\"638\" height=\"346\" srcset=\"https:\/\/nhathuocngocanh.com\/bp\/wp-content\/uploads\/2025\/11\/Tetryzoline-Hydrochloride-3.jpg 1200w, https:\/\/nhathuocngocanh.com\/bp\/wp-content\/uploads\/2025\/11\/Tetryzoline-Hydrochloride-3-300x163.jpg 300w, https:\/\/nhathuocngocanh.com\/bp\/wp-content\/uploads\/2025\/11\/Tetryzoline-Hydrochloride-3-1024x555.jpg 1024w, https:\/\/nhathuocngocanh.com\/bp\/wp-content\/uploads\/2025\/11\/Tetryzoline-Hydrochloride-3-768x416.jpg 768w\" sizes=\"auto, (max-width: 638px) 100vw, 638px\" \/><br \/>\nA. (1RS)-1,2,3,4-tetrahydronaphthalene-1-carbonitrile (\u03b1-cyanotetraline).<\/p>\n","protected":false},"excerpt":{"rendered":"<p>BP 2025 (Ph. Eur. 11.6 update) C13H17ClN2 236.7 522-48-5 Action and use Adrenoceptor agonist; decongestant. DEFINITION 2-[(1RS)-1,2,3,4-Tetrahydronaphthalen-1-yl]-4,5-dihydro-1H-imidazole hydrochloride. Content 98.0 per cent to 101.0 per cent (dried substance). CHARACTERS Appearance White or almost white, crystalline powder. Solubility Freely soluble in water, in anhydrous ethanol and in ethanol (96 per cent), practically insoluble in acetone. IDENTIFICATION&#8230;<\/p>\n","protected":false},"author":5,"featured_media":29772,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[174],"tags":[],"class_list":["post-29757","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-medicinal-substances"],"acf":[],"_links":{"self":[{"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/posts\/29757","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/comments?post=29757"}],"version-history":[{"count":2,"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/posts\/29757\/revisions"}],"predecessor-version":[{"id":29776,"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/posts\/29757\/revisions\/29776"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/media\/29772"}],"wp:attachment":[{"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/media?parent=29757"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/categories?post=29757"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/tags?post=29757"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}